Last updated 2025-12-02
How Much Is a Pharmacy Worth?
A pharmacy is typically worth 2x to 4x its seller's discretionary earnings (SDE), based on comparable transaction data from recent pharmacy business sales. For a business generating $1 million in annual revenue with the sector-average 12% net margin, that translates to an estimated value between $300K and $700K. The exact figure depends on profitability, growth trajectory, customer concentration, and how dependent the business is on its current owner.
Key Takeaway
A pharmacy is worth 2x to 4x SDE ($300K to $700K on $1M revenue). Profitability, growth, customer concentration, and owner dependency determine where your business falls in this range.
Conservative
$300K
0.3x revenue
Most Likely
$500K
0.5x revenue
Optimistic
$700K
0.7x revenue
Based on $1M annual revenue. Actual value varies by earnings and risk profile.
Pharmacy Value by Revenue Size
The table below estimates what a pharmacy is worth at different revenue levels using industry-standard revenue multiples of 0.3x–0.7x. Revenue-based estimates provide a quick benchmark, but pharmacy valuation multiples based on SDE and EBITDA produce more accurate results because they account for profitability differences between individual businesses.
| Annual Revenue | Conservative | Most Likely | Optimistic |
|---|---|---|---|
| $250K | $75K | $125K | $175K |
| $500K | $150K | $250K | $350K |
| $1M | $300K | $500K | $700K |
| $2M | $600K | $1M | $1.4M |
| $5M | $1.5M | $2.5M | $3.5M |
Revenue multiples: 0.3x (conservative) / 0.5x (median) / 0.7x (optimistic). For a personalized estimate using your actual earnings, run a free pharmacy valuation.
Three Ways to Value a Pharmacy
Professional business appraisers and experienced brokers use multiple methods to triangulate a fair market value. Each method answers a slightly different question about what a pharmacy is worth, and the most defensible valuations weight all three.
SDE Multiple Method
Best for owner-operated pharmacy businesses under $5M revenue
Seller's discretionary earnings represent the total financial benefit available to one full-time owner-operator. SDE adds back owner compensation, personal perks, depreciation, and interest to net income. This is the standard valuation basis for pharmacy businesses where the owner actively manages day-to-day operations.
EBITDA Multiple Method
Best for larger operations with hired management
Earnings before interest, taxes, depreciation, and amortization isolate operating profitability by removing capital structure and accounting decisions. EBITDA multiples are preferred for pharmacy businesses with revenue above $2M that employ a general manager, because the buyer will need to replace that role regardless of the valuation method chosen.
Revenue Multiple Method
Quick benchmark, does not account for profitability
Revenue multiples provide the simplest calculation (annual revenue times the industry multiple) but they are the least precise method because two pharmacy businesses with identical revenue can have vastly different profitability. Use revenue multiples as a sanity check against the SDE and EBITDA results, not as the primary valuation.
How Margin Changes Move the Valuation
Revenue-based estimates only tell part of the story. Profitability is the real engine: at the same $1M top line, a pharmacy running at 12% margin versus 8% margin produces very different SDE figures and therefore very different sale prices. The three scenarios below illustrate how a change in operating margin compounds through the multiple.
| Scenario | Revenue | Margin | Estimated SDE | Sale Value (mid multiple) |
|---|---|---|---|---|
| Below benchmark | $1M | 8% | $80K | $160K |
| At industry average | $1M | 12% | $120K | $360K |
| Top quartile performer | $1M | 16% | $160K | $640K |
Margin discipline and multiple selection both compound. The gap between the below-benchmark and top-quartile scenarios often exceeds the full asking price of the weaker business. For a detailed breakdown of the healthcare-specific factors that move your multiple, see our pharmacy valuation methodology page. To run the math on your own numbers, our free valuation calculator applies risk adjustments and returns a weighted estimate from all three methods.
Who Buys a Pharmacy?
Pharmacist-owners acquiring their second or third location represent the most common buyer type. Regional and national pharmacy chains occasionally acquire high-volume independents to expand geographic coverage, while healthcare systems may acquire pharmacies to control their outpatient prescription pipeline.
Frequently Asked Questions
How do you calculate the value of a pharmacy?
The most reliable approach uses three methods in parallel. First, calculate seller's discretionary earnings (SDE) and multiply by 2x–4x. Second, calculate EBITDA and apply a 4x–8x multiple. Third, apply a 0.3x–0.7x revenue multiple as a cross-check. Weighting these three estimates produces a defensible valuation range. Valzura's free calculator runs all three methods simultaneously using pharmacy industry data.
What multiple is used to value a pharmacy?
The most common multiple for smaller, owner-operated pharmacy businesses is 3x SDE (seller's discretionary earnings), within a range of 2x–4x. Larger operations with hired management use EBITDA multiples of 4x–8x instead. Where a specific business falls within these ranges depends on profitability, growth trends, customer concentration, and owner dependency.
How many times revenue is a pharmacy worth?
A pharmacy typically sells for 0.3x to 0.7x annual revenue, with a median of 0.5x. Revenue multiples are the simplest valuation method but the least precise because they ignore profitability differences. A pharmacy earning 12% net margins is worth substantially more per dollar of revenue than one earning half that margin.
What is the average profit margin for a pharmacy?
The average net profit margin for a pharmacy is approximately 12%. Businesses operating above this benchmark command higher valuation multiples because each dollar of revenue contributes more to the bottom line. Margins below the industry average compress multiples, even when top-line revenue is strong. Profit margin is one of the most significant factors buyers evaluate because it directly affects the return on their acquisition investment and the speed of payback.
How long does it take to sell a pharmacy?
Most pharmacy businesses sell within 6 to 12 months from listing to close. Businesses with clean financials, documented processes, and earnings above $500,000 SDE tend to sell faster, sometimes in 3 to 6 months. The timeline extends if the business has undocumented owner perks, inconsistent earnings, or unresolved lease or license issues that require buyer due diligence.
How do insurance reimbursement rates affect a pharmacy valuation?
Payor mix and reimbursement contract terms are central to healthcare valuation. A pharmacy with a favorable in-network mix, high commercial insurance share, and multi-year reimbursement agreements commands higher multiples than one dependent on Medicare, Medicaid, or out-of-network cash pay. Provide three years of payor mix data, CPT code utilization, and a summary of pending reimbursement rate changes as part of due diligence.
What happens to the value if the owner-provider leaves a pharmacy?
Owner-provider dependence is the single biggest risk factor in healthcare valuation. If the owner generates more than 50% of the revenue personally, buyers will discount the multiple significantly or require a 2-3 year earnout tied to patient retention. Mitigate this by hiring associate providers, documenting treatment protocols, and transferring patient relationships for 12-18 months before listing.
Find Out Exactly What Your Pharmacy Is Worth
Enter your actual revenue, expenses, and owner compensation. Our business worth calculator applies pharmacy-specific multiples and risk adjustments to produce a personalized valuation range in under two minutes.
Related Healthcare Business Values
Compare what other healthcare businesses sell for, or browse valuation data across all 52 industries.